SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001447028-23-000046
Filing Date
2023-05-26
Accepted
2023-05-26 16:22:45
Documents
3
Period of Report
2023-05-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1685132533.html 4  
1 FORM 4 wk-form4_1685132533.xml 4 4041
2 EX-24 poa-burgess.htm EX-24 3739
3 GRAPHIC poa-burgess001.jpg GRAPHIC 232174
  Complete submission text file 0001447028-23-000046.txt   329220
Mailing Address C/O HOLLIS-EDEN PHARMACEUTICALS 4435 EASTGATE MALL STE.400 SAN DIEGO CA 92121
Business Address
BURGESS DANIEL D (Reporting) CIK: 0001239650 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 23969295

Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations